Fundación Pública Galega de Medicina Xenómica
Centro de investigación
![Foto de Fundación Pública Galega de Medicina Xenómica](/img/noimage.png)
![Foto de University of Liverpool](/img/noimage_org.png)
University of Liverpool
Liverpool, Reino UnidoPublicacións en colaboración con investigadores/as de University of Liverpool (13)
2023
-
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681
-
Erratum: Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 (Nature (2023) 617 7962 (764-768))
Nature
-
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Nature, Vol. 617, Núm. 7962, pp. 764-768
2019
-
Identification of regulatory variants associated with genetic susceptibility to meningococcal disease
Scientific Reports, Vol. 9, Núm. 1
-
Plasma lipid profiles discriminate bacterial from viral infection in febrile children
Scientific Reports, Vol. 9, Núm. 1
-
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)
Nature Communications
-
Shared heritability and functional enrichment across six solid cancers
Nature Communications, Vol. 10, Núm. 1
2018
-
Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study
The Lancet Child and Adolescent Health, Vol. 2, Núm. 6, pp. 404-414
2017
-
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Nature Communications, Vol. 8
-
The oncoarray consortium: A network for understanding the genetic architecture of common cancers
Cancer Epidemiology Biomarkers and Prevention, Vol. 26, Núm. 1, pp. 126-135
2016
-
Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies
Scientific Reports, Vol. 6
-
Progress in pharmacogenetics: Consortiums and new strategies
Drug Metabolism and Personalized Therapy, Vol. 31, Núm. 1, pp. 17-23
2010
-
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
Nature Genetics, Vol. 42, Núm. 2, pp. 132-136